Publisher's note: This Perspective is one of the two winning Essays of the "Reimagine biomedical research for a healthier future"Essay challenge, launched by the Health Research Alliance in partnership with PLOS. This publication is coordinated with that of the other winning Essay in PLOS Biology. The competition was intended to spark a discussion around the future of biomedical research; publication does not imply endorsement from HRA or PLOS.
An open science pathway for drug marketing authorization-Registered drug approval
Cristea I. A.;
2021-01-01
Abstract
Publisher's note: This Perspective is one of the two winning Essays of the "Reimagine biomedical research for a healthier future"Essay challenge, launched by the Health Research Alliance in partnership with PLOS. This publication is coordinated with that of the other winning Essay in PLOS Biology. The competition was intended to spark a discussion around the future of biomedical research; publication does not imply endorsement from HRA or PLOS.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
